Synergism between ethanolic extract of propolis (EEP) and anti-tuberculosis drugs on growth of mycobacteria. 1999

S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
Department of Microbiology and Immunology, Silesian Academy of Medicine, Zabrze-Rokitnica, Poland.

Ethanolic extract of propolis exerts a strong anti-bacterial activity, in addition to antifungal, antiviral and antiprotozoal properties. In previous studies from these laboratories we have demonstrated that the intensity of the bactericidal activity of EEP is correlated with the virulence of the mycobacteria tested, and that EEP has a synergistic effect with antibiotics on growth of staphylococcus aureus. In the present study we investigated whether the same synergism and correlation exists between EEP and some anti-tuberculosis drugs on tuberculosis mycobacteria with different degrees of virulence. Six standard strains and 11 wild strains of mycobacteria were exposed for 30 days to EEP, with or without streptomycin, rifamycin, isoniazid or ethambutol. Out of the 17 strains, 8 were resistant to at least two standard antibiotics, and were considered "multi-resistant strains". The rest were either susceptible or resistant to only one of the antimycobacterial drugs. Antagonism was recorded only in one case, when Staphylococcus aureus were treated with a mixture of EEP and ethambutol, suggesting that a chemical bond could have been formed between this anti-tuberculosis antibiotic and one of the active components of the ethanol extract of propolis.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D011429 Propolis A resinous substance obtained from beehives that is used traditionally as an antimicrobial. It is a heterogeneous mixture of many substances. Bee Bread,Bee Glue,Bread, Bee,Glue, Bee
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
January 1990, Biochemistry international,
S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
January 1989, Zeitschrift fur Naturforschung. C, Journal of biosciences,
S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
February 2009, Molecules (Basel, Switzerland),
S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
January 2003, Microbiological research,
S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
August 2005, Memorias do Instituto Oswaldo Cruz,
S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
July 2020, Journal of food biochemistry,
S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
January 1980, Przeglad lekarski,
S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
October 1998, The Journal of pharmacy and pharmacology,
S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
May 1993, Arzneimittel-Forschung,
S Scheller, and S Dworniczak, and K Waldemar-Klimmek, and M Rajca, and A Tomczyk, and J Shani
January 1978, Arzneimittel-Forschung,
Copied contents to your clipboard!